Clinical Trial Update: A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the safety and efficacy of erlotinib plus bevacizumab in advanced thymic cancer and thymoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Cancer
• Thymoma

Drugs mentioned

• Avastin (bevacizumab)
• Tarceva (erlotinib)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Thymic Cancer, Thymoma | Phase 2 | Status: COMPLETED